273 related articles for article (PubMed ID: 30385267)
1. Antileishmanial activity of a 4-hydrazinoquinoline derivative: Induction of autophagy and apoptosis-related processes and effectiveness in experimental cutaneous leishmaniasis.
Antinarelli LMR; de Oliveira Souza I; Zabala Capriles PV; Gameiro J; Britta EA; Nakamura CV; Lima WP; da Silva AD; Coimbra ES
Exp Parasitol; 2018 Dec; 195():78-86. PubMed ID: 30385267
[TBL] [Abstract][Full Text] [Related]
2. Novel organic salts based on quinoline derivatives: The in vitro activity trigger apoptosis inhibiting autophagy in Leishmania spp.
Calixto SL; Glanzmann N; Xavier Silveira MM; da Trindade Granato J; Gorza Scopel KK; Torres de Aguiar T; DaMatta RA; Macedo GC; da Silva AD; Coimbra ES
Chem Biol Interact; 2018 Sep; 293():141-151. PubMed ID: 30098941
[TBL] [Abstract][Full Text] [Related]
3. 4-Aminoquinoline Derivatives as Potential Antileishmanial Agents.
Antinarelli LM; Dias RM; Souza IO; Lima WP; Gameiro J; da Silva AD; Coimbra ES
Chem Biol Drug Des; 2015 Oct; 86(4):704-14. PubMed ID: 25682728
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activity of novel 4-aminoquinoline/1,2,3-triazole hybrids against Leishmania amazonensis.
Glanzmann N; Antinarelli LMR; da Costa Nunes IK; Pereira HMG; Coelho EAF; Coimbra ES; da Silva AD
Biomed Pharmacother; 2021 Sep; 141():111857. PubMed ID: 34323702
[TBL] [Abstract][Full Text] [Related]
6. 4-Quinolinylhydrazone analogues kill Leishmania (Leishmania) amazonensis by inducing apoptosis and mitochondria-dependent pathway cell death.
Granato JDT; Silva ETD; Lemos ASO; Machado PA; Midlej VDV; Antinarelli LMR; Silva Neto AFD; Souza MVN; Coimbra ES
Chem Biol Drug Des; 2024 May; 103(5):e14535. PubMed ID: 38772877
[TBL] [Abstract][Full Text] [Related]
7. Semicarbazone derivatives as promising therapeutic alternatives in leishmaniasis.
Cavalcanti de Queiroz A; Alves MA; Barreiro EJ; Lima LM; Alexandre-Moreira MS
Exp Parasitol; 2019 Jun; 201():57-66. PubMed ID: 31004571
[TBL] [Abstract][Full Text] [Related]
8. VOSalophen: a vanadium complex with a stilbene derivative-induction of apoptosis, autophagy, and efficiency in experimental cutaneous leishmaniasis.
Machado PA; Moraes JOF; Carvalho GSG; Lima WP; Macedo GC; Britta EA; Nakamura CV; da Silva AD; Cuin A; Coimbra ES
J Biol Inorg Chem; 2017 Aug; 22(6):929-939. PubMed ID: 28597089
[TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of (-)α-bisabolol as a promising agent against Leishmania amazonensis.
Rottini MM; Amaral AC; Ferreira JL; Silva JR; Taniwaki NN; Souza Cda S; d'Escoffier LN; Almeida-Souza F; Hardoim Dde J; Gonçalves da Costa SC; Calabrese Kda S
Exp Parasitol; 2015 Jan; 148():66-72. PubMed ID: 25448354
[TBL] [Abstract][Full Text] [Related]
10. Poloxamer 407 (Pluronic(®) F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis.
Mendonça DV; Lage LM; Lage DP; Chávez-Fumagalli MA; Ludolf F; Roatt BM; Menezes-Souza D; Faraco AA; Castilho RO; Tavares CA; Barichello JM; Duarte MC; Coelho EA
Exp Parasitol; 2016 Oct; 169():34-42. PubMed ID: 27427166
[TBL] [Abstract][Full Text] [Related]
11. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
[TBL] [Abstract][Full Text] [Related]
12. Antileishmanial Activity, Cytotoxicity and Mechanism of Action of Clioquinol Against Leishmania infantum and Leishmania amazonensis Species.
Tavares GSV; Mendonça DVC; Lage DP; Granato JDT; Ottoni FM; Ludolf F; Chávez-Fumagalli MA; Duarte MC; Tavares CAP; Alves RJ; Coimbra ES; Coelho EAF
Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):236-246. PubMed ID: 29481714
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis.
Araújo IAC; de Paula RC; Alves CL; Faria KF; Oliveira MM; Mendes GG; Dias EMFA; Ribeiro RR; Oliveira AB; Silva SMD
Exp Parasitol; 2019 Apr; 199():67-73. PubMed ID: 30797783
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
[TBL] [Abstract][Full Text] [Related]
15. Effect of 1,2,3-triazole salts, non-classical bioisosteres of miltefosine, on Leishmania amazonensis.
Stroppa PHF; Antinarelli LMR; Carmo AML; Gameiro J; Coimbra ES; da Silva AD
Bioorg Med Chem; 2017 Jun; 25(12):3034-3045. PubMed ID: 28433512
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of the local or oral delivery of the novel naphthopterocarpanquinone LQB-118 against cutaneous leishmaniasis.
da Cunha-Júnior EF; Pacienza-Lima W; Ribeiro GA; Netto CD; do Canto-Cavalheiro MM; da Silva AJ; Costa PR; Rossi-Bergmann B; Torres-Santos EC
J Antimicrob Chemother; 2011 Jul; 66(7):1555-9. PubMed ID: 21531758
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of the 7-chloro-4-(3-hydroxy-benzilidenehydrazo)quinoline derivative against infection caused by Leishmania amazonensis.
Antinarelli LMR; Souza MVN; Coelho EAF; Lima WP; Coimbra ES
Rev Soc Bras Med Trop; 2020; 53():e20200091. PubMed ID: 32578713
[TBL] [Abstract][Full Text] [Related]
18. Aryl thiosemicarbazones: In vitro and immunomodulatory activities against L. amazonensis.
da Silva AC; Dos Santos TAR; da Silva IVB; de Oliveira MVG; Moreira DRM; Leite ACL; Pereira VRA
Exp Parasitol; 2017 Jun; 177():57-65. PubMed ID: 28433563
[TBL] [Abstract][Full Text] [Related]
19. N-butyl-[1-(4-methoxy)phenyl-9H-β-carboline]-3-carboxamide prevents cytokinesis in Leishmania amazonensis.
Stefanello TF; Panice MR; Ueda-Nakamura T; Sarragiotto MH; Auzély-Velty R; Nakamura CV
Antimicrob Agents Chemother; 2014 Dec; 58(12):7112-20. PubMed ID: 25224005
[TBL] [Abstract][Full Text] [Related]
20. C5 induces different cell death pathways in promastigotes of Leishmania amazonensis.
Mendes EA; Desoti VC; Silva Sde O; Ueda-Nakamura T; Dias Filho BP; Yamada-Ogatta SF; Sarragiotto MH; Nakamura CV
Chem Biol Interact; 2016 Aug; 256():16-24. PubMed ID: 27317947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
